{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:11:36Z","timestamp":1790007096597,"version":"4.0.1"},"reference-count":159,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>To discuss the application of mitomycin C (MMC) in ophthalmic surgical procedures, including dosage, method of application, reported complications, and follow-up results.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A comprehensive literature search was conducted on PubMed, Google Scholar, and the Cochrane Library without date limitations using keywords: mitomycin, ophthalmic, and surgery. The original articles used as references were first graded using a 0 to 5 grading scale devised by the authors to ensure the uniformity of reference selection. Only those original articles grading 3 or above based on this grading scale were used as references. The last search was conducted in March 2024.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>MMC has been widely utilized in ophthalmic surgery due to its effects on the wound-healing process. The main current applications include pterygium surgery, glaucoma filtering surgery, surgical treatment of ocular surface tumors, eye alignment surgeries, dacryocystorhinostomy, and corneal refractive surgery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>The dosage and duration of MMC application in ophthalmic surgery depend on the specific procedure, with ongoing controversies regarding the optimal dosage. In addition, it is essential to consider complications when evaluating the cost-benefit of MMC use. Further randomized clinical trials with larger sample sizes and longer follow-up periods are warranted, with a specific focus on reducing long-term side effects, refining dosage guidelines, and exploring MMC\u2019s role in combination therapies for various ophthalmic procedures.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/joco.joco_283_23","type":"journal-article","created":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T16:04:06Z","timestamp":1749139446000},"page":"211-222","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":10,"title":["Use of Mitomycin C in Ophthalmic Surgery"],"prefix":"10.4103","volume":"36","author":[{"given":"Nader","family":"Nassiri","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Imam Hossein Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran"},{"name":"Labbafinezhad Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kourosh","family":"Sheibani","sequence":"additional","affiliation":[{"name":"Basir Eye Health Research Center, Iran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Kavousnezhad","sequence":"additional","affiliation":[{"name":"Vanak Eye Surgery Center, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saman","family":"Nassiri","sequence":"additional","affiliation":[{"name":"St. John Episcopal Hospital, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Azemati","sequence":"additional","affiliation":[{"name":"Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nariman","family":"Nassiri","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Doheny Eye Institute, University of California at Los Angeles, Pasadena, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,6,5]]},"reference":[{"key":"R1-20250605","first-page":"141","article-title":"Mitomycin, a new antibiotic from streptomyces. I","volume":"9","author":"Hata","year":"1956","journal-title":"J Antibiot (Tokyo)"},{"key":"R2-20250605","doi-asserted-by":"crossref","first-page":"5365","DOI":"10.3390\/molecules25225365","article-title":"Anticancer drug discovery from microbial sources: The unique mangrove streptomycetes","volume":"25","author":"Law","year":"2020","journal-title":"Molecules"},{"key":"R3-20250605","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/ICO.0b013e31821e429d","article-title":"Mitomycin C: Biological effects and use in refractive surgery","volume":"31","author":"Santhiago","year":"2012","journal-title":"Cornea"},{"key":"R4-20250605","first-page":"533","article-title":"Clinical trials of mitomycin C, a new antitumor antibiotic; preliminary report of results obtained in 82 consecutive cases in the field of general surgery","volume":"6","author":"Shiraha","year":"1958","journal-title":"Antibiot Annu"},{"key":"R5-20250605","first-page":"79","article-title":"Recent advance in research on antitumor mitomycins","volume":"13","author":"Wakaki","year":"1961","journal-title":"Cancer Chemother Rep"},{"key":"R6-20250605","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0161-6420(99)90022-2","article-title":"Subconjunctival mitomycin C for the treatment of ocular cicatricial pemphigoid","volume":"106","author":"Donnenfeld","year":"1999","journal-title":"Ophthalmology"},{"key":"R7-20250605","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1517\/14740338.6.1.27","article-title":"Uses and complications of mitomycin C in ophthalmology","volume":"6","author":"Mearza","year":"2007","journal-title":"Expert Opin Drug Saf"},{"key":"R8-20250605","doi-asserted-by":"crossref","first-page":"437","DOI":"10.7164\/antibiotics.39.437","article-title":"New mitomycin analogs produced by directed biosynthesis","volume":"39","author":"Claridge","year":"1986","journal-title":"J Antibiot (Tokyo)"},{"key":"R9-20250605","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/(SICI)1097-0215(19970807)72:4<649::AID-IJC17>3.0.CO;2-6","article-title":"Molecular targeting of mitomycin C chemotherapy","volume":"72","author":"Nishiyama","year":"1997","journal-title":"Int J Cancer"},{"key":"R10-20250605","first-page":"601","article-title":"Studies on the pterygium. Part 4: A treatment of the pterygium by mitomycin-C instillation","volume":"67","author":"Kunitomo","year":"1963","journal-title":"Nippon Ganka Gakkai Zasshi"},{"key":"R11-20250605","first-page":"172","article-title":"Enhanced intraocular pressure controlling effectiveness of trabeculectomy by local application of mitomycin C","volume":"9","author":"Chen","year":"1983","journal-title":"Trans Asia Pac Acad Ophthalmol"},{"key":"R12-20250605","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1136\/bjo.2005.086850","article-title":"Complications of mitomycin C therapy in 100 eyes with ocular surface neoplasia","volume":"90","author":"Khong","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"R13-20250605","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1001\/archopht.1995.01100010021008","article-title":"Necrotizing keratitis following trabeculectomy with mitomycin","volume":"113","author":"Oram","year":"1995","journal-title":"Arch Ophthalmol"},{"key":"R14-20250605","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0002-9394(14)76738-8","article-title":"Development of scleral ulceration and calcification after pterygium excision and mitomycin therapy","volume":"112","author":"Dunn","year":"1991","journal-title":"Am J Ophthalmol"},{"key":"R15-20250605","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1007\/s40123-022-00535-6","article-title":"Topical chemotherapy for treating ocular surface squamous neoplasia with a combination of interferon \u03b1-2b and 5-fluorouracil","volume":"11","author":"Geng","year":"2022","journal-title":"Ophthalmol Ther"},{"key":"R16-20250605","doi-asserted-by":"crossref","first-page":"11357","DOI":"10.3390\/ijerph191811357","article-title":"Evaluating the efficacy and safety of different pterygium surgeries: A review of the literature","volume":"19","author":"Palewski","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"R17-20250605","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/eye.2017.196","article-title":"Immunoreduction of ocular surface tumours with intralesional interferon alpha-2a","volume":"32","author":"Kim","year":"2018","journal-title":"Eye (Lond)"},{"key":"R18-20250605","doi-asserted-by":"crossref","first-page":"e0174450","DOI":"10.1371\/journal.pone.0174450","article-title":"Prevalence and associated factors of pterygium among adults living in Gondar city, Northwest Ethiopia","volume":"12","author":"Anbesse","year":"2017","journal-title":"PLoS One"},{"key":"R19-20250605","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/S0161-6420(03)00091-5","article-title":"Subconjunctival mitomycin C as adjunctive therapy before pterygium excision","volume":"110","author":"Donnenfeld","year":"2003","journal-title":"Ophthalmology"},{"key":"R20-20250605","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/j.1755-3768.1992.tb02127.x","article-title":"Excimer laser treatment of pterygium","volume":"70","author":"Krag","year":"1992","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"R21-20250605","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ajo.2017.07.004","article-title":"Conjunctival autograft versus amniotic membrane transplantation for treatment of pterygium: Findings from a Cochrane systematic review","volume":"182","author":"Clearfield","year":"2017","journal-title":"Am J Ophthalmol"},{"key":"R22-20250605","doi-asserted-by":"crossref","first-page":"667","DOI":"10.3928\/1542-8877-19960801-05","article-title":"Indications for and complications of mitomycin-C in pterygium surgery","volume":"27","author":"Anduze","year":"1996","journal-title":"Ophthalmic Surg Lasers"},{"key":"R23-20250605","doi-asserted-by":"crossref","first-page":"29","DOI":"10.29328\/journal.hceo.1001004","article-title":"Mitomycin-C use and complications in ophthalmology","volume":"1","author":"Cumurcu","year":"2017","journal-title":"Int J Clin Exp Ophthalmol"},{"key":"R24-20250605","first-page":"12","article-title":"Mitomycin-C use in ophthalmology","volume":"3","author":"Singh","year":"2017","journal-title":"IOSR J Pharm"},{"key":"R25-20250605","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/j.ophtha.2004.02.007","article-title":"Long-term effects of mitomycin C in pterygium surgery on scleral thickness and the conjunctival epithelium","volume":"111","author":"Solomon","year":"2004","journal-title":"Ophthalmology"},{"key":"R26-20250605","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1136\/bjo.84.4.385","article-title":"Analysis of variation in success rates in conjunctival autografting for primary and recurrent pterygium","volume":"84","author":"Ti","year":"2000","journal-title":"Br J Ophthalmol"},{"key":"R27-20250605","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1001\/archophthalmol.2012.2599","article-title":"Limbal-conjunctival versus conjunctival autograft transplant for recurrent pterygia: A prospective randomized controlled trial","volume":"131","author":"Al Fayez","year":"2013","journal-title":"JAMA Ophthalmol"},{"key":"R28-20250605","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.sjopt.2017.11.002","article-title":"Comparison of conjunctival autograft and conjunctival transposition flap techniques in primary pterygium surgery","volume":"32","author":"Bilge","year":"2018","journal-title":"Saudi J Ophthalmol"},{"key":"R29-20250605","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.2147\/OPTH.S186543","article-title":"How to minimize pterygium recurrence rates: Clinical perspectives","volume":"12","author":"Nuzzi","year":"2018","journal-title":"Clin Ophthalmol"},{"key":"R30-20250605","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1136\/bjo.2003.036830","article-title":"A randomised trial comparing 0.02% mitomycin C and limbal conjunctival autograft after excision of primary pterygium","volume":"88","author":"Young","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"R31-20250605","doi-asserted-by":"crossref","first-page":"8820926","DOI":"10.1155\/2021\/8820926","article-title":"Evaluation of conjunctival autografting augmented with mitomycin C application versus ologen implantation in the surgical treatment of recurrent pterygium","volume":"2021","author":"Wagdy","year":"2021","journal-title":"J Ophthalmol"},{"key":"R32-20250605","doi-asserted-by":"crossref","first-page":"175","DOI":"10.4274\/tjo.galenos.2023.97932","article-title":"Applications of mitomycin C in cornea and external disease","volume":"53","author":"Crespo","year":"2023","journal-title":"Turk J Ophthalmol"},{"key":"R33-20250605","doi-asserted-by":"crossref","first-page":"981663","DOI":"10.3389\/fmed.2022.981663","article-title":"Amniotic membrane transplantation and conjunctival autograft combined with mitomycin C for the management of primary pterygium: A systematic review and meta-analysis","volume":"9","author":"Taher","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"R34-20250605","first-page":"23","article-title":"Amniotic membrane transplantation for primary pterygium surgery","volume":"3","author":"Katbaab","year":"2008","journal-title":"J Ophthalmic Vis Res"},{"key":"R35-20250605","doi-asserted-by":"crossref","first-page":"705","DOI":"10.2147\/OPTH.S80102","article-title":"The use of dry amniotic membrane in pterygium surgery","volume":"10","author":"Noureddin","year":"2016","journal-title":"Clin Ophthalmol"},{"key":"R36-20250605","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jtos.2014.01.001","article-title":"Surgical management of pterygium","volume":"12","author":"Janson","year":"2014","journal-title":"Ocul Surf"},{"key":"R37-20250605","first-page":"352","article-title":"Effectiveness of amniotic membrane transplantation combined with mitomycin C in the treatment of pterygium: A meta-analysis","volume":"3","author":"Song","year":"2010","journal-title":"Int J Ophthalmol"},{"key":"R38-20250605","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/ICO.0000000000001407","article-title":"Amniotic membrane grafts to reduce pterygium recurrence","volume":"37","author":"Rosen","year":"2018","journal-title":"Cornea"},{"key":"R39-20250605","first-page":"465","article-title":"Mitomycin C in pterygium treatment","volume":"9","author":"Martins","year":"2016","journal-title":"Int J Ophthalmol"},{"key":"R40-20250605","doi-asserted-by":"crossref","first-page":"321","DOI":"10.2165\/00003495-200666030-00005","article-title":"Mitomycin: Clinical applications in ophthalmic practice","volume":"66","author":"Abraham","year":"2006","journal-title":"Drugs"},{"key":"R41-20250605","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/00003226-200203000-00022","article-title":"Acute scleral thinning after pterygium excision with intraoperative mitomycin C: A case report of scleral dellen after bare sclera technique and review of the literature","volume":"21","author":"Tsai","year":"2002","journal-title":"Cornea"},{"key":"R42-20250605","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3906\/sag-1408-32","article-title":"Intraoperative application of 5-fluorouracil and mitomycin C aschemoadjuvants in primary pterygium surgery","volume":"46","author":"Altay","year":"2016","journal-title":"Turk J Med Sci"},{"key":"R43-20250605","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1097\/OPX.0000000000000352","article-title":"Alcohol-assisted debridement in PRK with intraoperative mitomycin C","volume":"91","author":"Nassiri","year":"2014","journal-title":"Optom Vis Sci"},{"key":"R44-20250605","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.jcrs.2008.03.007","article-title":"Corneal endothelial cell injury induced by mitomycin-C in photorefractive keratectomy: Nonrandomized controlled trial","volume":"34","author":"Nassiri","year":"2008","journal-title":"J Cataract Refract Surg"},{"key":"R45-20250605","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.survophthal.2009.04.002","article-title":"Mitomycin C in corneal refractive surgery","volume":"54","author":"Teus","year":"2009","journal-title":"Surv Ophthalmol"},{"key":"R46-20250605","doi-asserted-by":"crossref","first-page":"2841408","DOI":"10.1155\/2017\/2841408","article-title":"Effect of mitomycin C on myopic versus astigmatic photorefractive keratectomy","volume":"2017","author":"Almosa","year":"2017","journal-title":"J Ophthalmol"},{"key":"R47-20250605","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1001\/archopht.1991.01080080101040","article-title":"Modulation of corneal wound healing after excimer laser keratomileusis using topical mitomycin C and steroids","volume":"109","author":"Talamo","year":"1991","journal-title":"Arch Ophthalmol"},{"key":"R48-20250605","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0161-6420(99)00019-6","article-title":"Topical mitomycin-C for subepithelial fibrosis after refractive corneal surgery","volume":"107","author":"Majmudar","year":"2000","journal-title":"Ophthalmology"},{"key":"R49-20250605","doi-asserted-by":"crossref","first-page":"484","DOI":"10.4103\/0974-9233.167821","article-title":"One year outcomes of photorefractive keratectomy with the application of mitomycin-C in the treatment of mild to moderate hyperopia","volume":"22","author":"Habibollahi","year":"2015","journal-title":"Middle East Afr J Ophthalmol"},{"key":"R50-20250605","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1177\/112067210601600206","article-title":"Photorefractive keratectomy in high myopic defects with or without intraoperative mitomycin C: 1-year results","volume":"16","author":"Bedei","year":"2006","journal-title":"Eur J Ophthalmol"},{"key":"R51-20250605","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3928\/1081-597X-20070301-04","article-title":"Prophylactic mitomycin C to inhibit corneal haze after photorefractive keratectomy for residual myopia following radial keratotomy","volume":"23","author":"Nassaralla","year":"2007","journal-title":"J Refract Surg"},{"key":"R52-20250605","first-page":"42","article-title":"Photorefractive keratectomy with mitomycin-C for high myopia: Three year follow-up results","volume":"55","author":"Hashemi","year":"2017","journal-title":"Acta Med Iran"},{"key":"R53-20250605","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ophtha.2004.07.035","article-title":"Mitomycin C modulation of corneal wound healing after photorefractive keratectomy in highly myopic eyes","volume":"112","author":"Gambato","year":"2005","journal-title":"Ophthalmology"},{"key":"R54-20250605","first-page":"204","article-title":"Comparison of standard and low dose intraoperative mitomycin C in prevention of corneal haze after photorefractive keratectomy","volume":"4","author":"Razmjoo","year":"2013","journal-title":"Int J Prev Med"},{"key":"R55-20250605","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1167\/iovs.02-0977","article-title":"Apoptosis in keratocytes caused by mitomycin C","volume":"44","author":"Kim","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R56-20250605","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.ajo.2006.04.029","article-title":"Intraoperative mitomycin and corneal endothelium after photorefractive keratectomy","volume":"142","author":"Morales","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"R57-20250605","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jcrs.2012.09.016","article-title":"Short-time mitomycin-C application during photorefractive keratectomy in patients with low myopia","volume":"39","author":"Shojaei","year":"2013","journal-title":"J Cataract Refract Surg"},{"key":"R58-20250605","doi-asserted-by":"crossref","first-page":"894","DOI":"10.3928\/1081597X-20090617-10","article-title":"Impact on the corneal endothelium of mitomycin C during photorefractive keratectomy","volume":"25","author":"Roh","year":"2009","journal-title":"J Refract Surg"},{"key":"R59-20250605","doi-asserted-by":"crossref","first-page":"724","DOI":"10.3928\/1081-597X-20070901-14","article-title":"Effect of mitomycin C on the corneal endothelium when used for corneal subepithelial haze prophylaxis following photorefractive keratectomy","volume":"23","author":"Goldsberry","year":"2007","journal-title":"J Refract Surg"},{"key":"R60-20250605","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1016\/S0886-3350(02)01701-7","article-title":"Evaluation of the prophylactic use of mitomycin-C to inhibit haze formation after photorefractive keratectomy","volume":"28","author":"Carones","year":"2002","journal-title":"J Cataract Refract Surg"},{"key":"R61-20250605","doi-asserted-by":"crossref","first-page":"672146","DOI":"10.1155\/2014\/672146","article-title":"Laser-assisted subepithelial keratectomy versus laser in situ keratomileusis in myopia: A systematic review and meta-analysis","volume":"2014","author":"Zhao","year":"2014","journal-title":"ISRN Ophthalmol"},{"key":"R62-20250605","doi-asserted-by":"crossref","first-page":"782","DOI":"10.3928\/1081-597X-20061001-08","article-title":"Comparison of laser epithelial keratomileusis with and without the use of mitomycin C","volume":"22","author":"Argento","year":"2006","journal-title":"J Refract Surg"},{"key":"R63-20250605","doi-asserted-by":"crossref","first-page":"813","DOI":"10.3928\/1081597X-20171004-06","article-title":"Long-term follow-up of LASEK with mitomycin c performed to correct myopia in thin corneas","volume":"33","author":"Garcia-Gonzalez","year":"2017","journal-title":"J Refract Surg"},{"key":"R64-20250605","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.ajo.2008.01.013","article-title":"Stability of laser epithelial keratomileusis with and without mitomycin C performed to correct myopia in thin corneas: A 15-month follow-up","volume":"145","author":"de Benito-Llopis","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"R65-20250605","doi-asserted-by":"crossref","first-page":"e7076","DOI":"10.1097\/MD.0000000000007076","article-title":"Predictability and stability of laser-assisted subepithelial keratectomy with mitomycin C for the correction of high myopia","volume":"96","author":"Iu","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"R66-20250605","doi-asserted-by":"crossref","first-page":"S693","DOI":"10.3928\/1081-597X-20040903-13","article-title":"Laser epithelial keratomileusis with mitomycin C: indications and limits","volume":"20","author":"Camellin","year":"2004","journal-title":"J Refract Surg"},{"key":"R67-20250605","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0002-9394(14)73072-7","article-title":"Mitomycin C therapy for corneal intraepithelial neoplasia","volume":"117","author":"Frucht-Pery","year":"1994","journal-title":"Am J Ophthalmol"},{"key":"R68-20250605","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0002-9394(02)01400-9","article-title":"Topical mitomycin C for extensive, recurrent conjunctival-corneal squamous cell carcinoma","volume":"133","author":"Shields","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"R69-20250605","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/01.ico.0000148314.86557.6a","article-title":"Topical 0.002% mitomycin C for the treatment of conjunctival-corneal intraepithelial neoplasia and squamous cell carcinoma","volume":"24","author":"Prabhasawat","year":"2005","journal-title":"Cornea"},{"key":"R70-20250605","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1136\/bjo.2009.176099","article-title":"Topical mitomycin C chemotherapy in the management of ocular surface neoplasia: A 10-year review of treatment outcomes and complications","volume":"94","author":"Russell","year":"2010","journal-title":"Br J Ophthalmol"},{"key":"R71-20250605","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1016\/j.ophtha.2011.01.060","article-title":"Outcomes in 15 patients with conjunctival melanoma treated with adjuvant topical mitomycin C: Complications and recurrences","volume":"118","author":"Ditta","year":"2011","journal-title":"Ophthalmology"},{"key":"R72-20250605","first-page":"154","article-title":"Topical Therapy for ocular surface squamous neoplasia","volume":"6","author":"Bitner","year":"2013","journal-title":"US Ophthalmic Rev"},{"key":"R73-20250605","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1136\/bjo.2009.160820","article-title":"Topical chemotherapy for ocular surface squamous neoplasia: Current status","volume":"94","author":"Sepulveda","year":"2010","journal-title":"Br J Ophthalmol"},{"key":"R74-20250605","first-page":"17","article-title":"The role of mitomycin C in Ocular Surface Squamous Neoplasia (OSSN)","volume":"3","author":"Kumar","year":"2016","journal-title":"J Med Dent Sci Res"},{"key":"R75-20250605","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1136\/bjo.2009.168294","article-title":"Treatment of ocular surface squamous neoplasia with mitomycin C","volume":"94","author":"Gupta","year":"2010","journal-title":"Br J Ophthalmol"},{"key":"R76-20250605","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/IOP.0b013e3181ac4c39","article-title":"Long-term results of topical mitomycin C 0.02% for primary and recurrent conjunctival-corneal intraepithelial neoplasia","volume":"25","author":"Ballalai","year":"2009","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"R77-20250605","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1136\/bjo.84.8.903","article-title":"Results of intraoperative mitomycin C application in dacryocystorhinostomy","volume":"84","author":"Liao","year":"2000","journal-title":"Br J Ophthalmol"},{"key":"R78-20250605","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1177\/112067210401400602","article-title":"Results of the application of intraoperative mitomycin C in dacryocystorhinostomy","volume":"14","author":"Roozitalab","year":"2004","journal-title":"Eur J Ophthalmol"},{"key":"R79-20250605","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1089\/jop.2013.0230","article-title":"Clinical outcomes of dacryocystorhinostomy with or without intraoperative use of mitomycin C: A systematic review and meta-analysis","volume":"30","author":"Qian","year":"2014","journal-title":"J Ocul Pharmacol Ther"},{"key":"R80-20250605","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3928\/0191-3913-19960301-06","article-title":"Evaluation of mitomycin to limit postoperative adhesions in strabismus surgery","volume":"33","author":"Cruz","year":"1996","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"R81-20250605","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3928\/0191-3913-20010501-05","article-title":"Effectiveness of mitomycin C in reducing reformation of adhesions following surgery for restrictive strabismus","volume":"38","author":"Mahindrakar","year":"2001","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"R82-20250605","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1089\/jop.2005.21.406","article-title":"Evaluation of mitomycin C in reducing postoperative adhesions in strabismus surgery","volume":"21","author":"Chen","year":"2005","journal-title":"J Ocul Pharmacol Ther"},{"key":"R83-20250605","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.ajo.2011.08.005","article-title":"Subconjunctival bevacizumab versus mitomycin C adjunctive to trabeculectomy","volume":"153","author":"Nilforushan","year":"2012","journal-title":"Am J Ophthalmol"},{"key":"R84-20250605","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3928\/1542-8877-19990601-11","article-title":"Surgical results and complications of mitomycin C-augmented trabeculectomy in refractory developmental glaucoma","volume":"30","author":"Mandal","year":"1999","journal-title":"Ophthalmic Surg Lasers"},{"key":"R85-20250605","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.ophtha.2004.01.028","article-title":"Bleb-associated endophthalmitis: Clinical characteristics and visual outcomes","volume":"111","author":"Busbee","year":"2004","journal-title":"Ophthalmology"},{"key":"R86-20250605","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/00061198-200604000-00002","article-title":"Determinants of bleb morphology in minimally invasive, clear-cornea micropenetrating glaucoma surgery with mitomycin C","volume":"15","author":"Kessing","year":"2006","journal-title":"J Glaucoma"},{"key":"R87-20250605","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/S0161-6420(02)01069-2","article-title":"Efficacy and safety of mitomycin-C in primary trabeculectomy: Five-year follow-up","volume":"109","author":"Bindlish","year":"2002","journal-title":"Ophthalmology"},{"key":"R88-20250605","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3341\/kjo.1993.7.1.1","article-title":"Effects of topical mitomycin C on glaucoma filtration surgery","volume":"7","author":"Hong","year":"1993","journal-title":"Korean J Ophthalmol"},{"key":"R89-20250605","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s10384-004-0181-9","article-title":"Efficacy and complications after trabeculectomy with mitomycin C in normal-tension glaucoma","volume":"49","author":"Jongsareejit","year":"2005","journal-title":"Jpn J Ophthalmol"},{"key":"R90-20250605","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1136\/bjo.2009.164384","article-title":"Clinical outcomes of epi-LASIK: 1-year results of on- and off-flap procedures with and without mitomycin-C","volume":"94","author":"Kim","year":"2010","journal-title":"Br J Ophthalmol"},{"key":"R91-20250605","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3928\/1081597X-20091209-03","article-title":"LASIK flap buttonhole treated immediately by PRK with mitomycin C","volume":"26","author":"Kymionis","year":"2010","journal-title":"J Refract Surg"},{"key":"R92-20250605","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1159\/000055691","article-title":"A morphological study of drill holes applied with mitomycin-C in hydroxyapatite orbital implants","volume":"33","author":"Lew","year":"2001","journal-title":"Ophthalmic Res"},{"key":"R93-20250605","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.3928\/1081597X-20080101-12","article-title":"Photorefractive keratectomy with 0.02% mitomycin C for treatment of residual refractive errors after LASIK","volume":"24","author":"Srinivasan","year":"2008","journal-title":"J Refract Surg"},{"key":"R94-20250605","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1089\/108076802760116179","article-title":"A comparative study of effects of antiproliferative drugs on human retinal pigment epithelial cells in vitro","volume":"18","author":"Wu","year":"2002","journal-title":"J Ocul Pharmacol Ther"},{"key":"R95-20250605","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/S0161-6420(95)30759-2","article-title":"Long-term results using adjunctive mitomycin C in optic nerve sheath decompression for pseudotumor cerebri","volume":"102","author":"Spoor","year":"1995","journal-title":"Ophthalmology"},{"key":"R96-20250605","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/S0161-6420(98)97024-5","article-title":"Decrease of capsular opacification with adjunctive mitomycin C in combined glaucoma and cataract surgery","volume":"105","author":"Shin","year":"1998","journal-title":"Ophthalmology"},{"key":"R97-20250605","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0161-6420(99)00096-2","article-title":"A randomized trial of low-dose, topical mitomycin-C in the treatment of severe vernal keratoconjunctivitis","volume":"107","author":"Akpek","year":"2000","journal-title":"Ophthalmology"},{"key":"R98-20250605","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4103\/0301-4738.25832","article-title":"Low dose mitomycin-C in severe vernal keratoconjunctivitis: A randomized prospective double blind study","volume":"54","author":"Jain","year":"2006","journal-title":"Indian J Ophthalmol"},{"key":"R99-20250605","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1097\/01.ico.0000157410.68148.d6","article-title":"Treatment of cystic epithelial downgrowth with intralesional administration of mitomycin C","volume":"24","author":"Yu","year":"2005","journal-title":"Cornea"},{"key":"R100-20250605","doi-asserted-by":"crossref","first-page":"255","DOI":"10.5935\/0004-2749.20150066","article-title":"Corneal melanosis successfully treated using topical mitomycin-C and alcohol corneal epitheliectomy: A 3-year follow-up case report","volume":"78","author":"Balc\u0131","year":"2015","journal-title":"Arq Bras Oftalmol"},{"key":"R101-20250605","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0002-9394(14)71867-7","article-title":"Corneoscleral, ciliary body, and vitreoretinal toxicity after excessive instillation of mitomycin C","volume":"114","author":"Gupta","year":"1992","journal-title":"Am J Ophthalmol"},{"key":"R102-20250605","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/j.jcrs.2006.05.014","article-title":"Cellular effects of mitomycin-C on human corneas after photorefractive keratectomy","volume":"32","author":"Rajan","year":"2006","journal-title":"J Cataract Refract Surg"},{"key":"R103-20250605","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.clae.2006.08.001","article-title":"Scleral melting 16 years after pterygium excision with topical mitomycin C adjuvant therapy","volume":"29","author":"Wan","year":"2006","journal-title":"Cont Lens Anterior Eye"},{"key":"R104-20250605","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1177\/112067210901900634","article-title":"Herpetic keratitis and keratouveitis after mitomycin-C use in glaucoma filtering surgery: A short case series","volume":"19","author":"Rao","year":"2009","journal-title":"Eur J Ophthalmol"},{"key":"R105-20250605","doi-asserted-by":"crossref","first-page":"286","DOI":"10.18295\/2075-0528.1279","article-title":"Late corneal thinning and keratitis following mitomycin-C use in pterygium surgery","volume":"11","author":"Shenoy","year":"2011","journal-title":"Sultan Qaboos Univ Med J"},{"key":"R106-20250605","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/s41433-019-0639-0","article-title":"Infectious keratitis after pterygium surgery","volume":"34","author":"Soleimani","year":"2020","journal-title":"Eye (Lond)"},{"key":"R107-20250605","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0161-6420(96)30639-8","article-title":"Bleb-related endophthalmitis after trabeculectomy with mitomycin C","volume":"103","author":"Higginbotham","year":"1996","journal-title":"Ophthalmology"},{"key":"R108-20250605","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3928\/1542-8877-19990201-12","article-title":"Late bleb-related endophthalmitis after trabeculectomy with mitomycin C","volume":"30","author":"Akova","year":"1999","journal-title":"Ophthalmic Surg Lasers"},{"key":"R109-20250605","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0002-9394(03)00207-1","article-title":"Intumescent cataract after topical mitomycin-C for conjunctival malignant melanoma","volume":"136","author":"Sacu","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"R110-20250605","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/S0161-6420(92)31749-X","article-title":"Serious complications of topical mitomycin-C after pterygium surgery","volume":"99","author":"Rubinfeld","year":"1992","journal-title":"Ophthalmology"},{"key":"R111-20250605","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1023\/A:1006024522541","article-title":"Ocular hypotony after laser suture lysis following trabeculectomy with mitomycin C","volume":"21","author":"Bardak","year":"1997","journal-title":"Int Ophthalmol"},{"key":"R112-20250605","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0002-9394(14)71349-2","article-title":"Ocular hypotony after trabeculectomy with mitomycin C","volume":"116","author":"Zacharia","year":"1993","journal-title":"Am J Ophthalmol"},{"key":"R113-20250605","doi-asserted-by":"crossref","first-page":"e251718","DOI":"10.1136\/bcr-2022-251718","article-title":"Conjunctival advancement for management of hypotony maculopathy after trabeculectomy","volume":"15","author":"Satpute","year":"2022","journal-title":"BMJ Case Rep"},{"key":"R114-20250605","doi-asserted-by":"crossref","first-page":"257","DOI":"10.4103\/2008-322X.170345","article-title":"Effect of mitomycin-C augmented trabeculectomy on corneal endothelial cells","volume":"10","author":"Zarei","year":"2015","journal-title":"J Ophthalmic Vis Res"},{"key":"R115-20250605","doi-asserted-by":"crossref","first-page":"301","DOI":"10.29271\/jcpsp.2018.04.301","article-title":"Comparison of mean corneal endothelial cell loss after trabeculectomy with and without mitomycin C","volume":"28","author":"Shaheer","year":"2018","journal-title":"J Coll Physicians Surg Pak"},{"key":"R116-20250605","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1016\/S0161-6420(96)30405-3","article-title":"A placebo-controlled, double-masked evaluation of mitomycin C in combined glaucoma and cataract procedures","volume":"103","author":"Cohen","year":"1996","journal-title":"Ophthalmology"},{"key":"R117-20250605","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1097\/IJG.0b013e3181659e56","article-title":"Corneal endothelial cell loss after mitomycin C-augmented trabeculectomy","volume":"17","author":"Storr-Paulsen","year":"2008","journal-title":"J Glaucoma"},{"key":"R118-20250605","first-page":"19","article-title":"Corneal complications of intraoperative mitomycin C in glaucoma surgery","volume":"314","author":"Coppens","year":"2010","journal-title":"Bull Soc Belge Ophtalmol"},{"key":"R119-20250605","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1136\/bjophthalmol-2016-309188","article-title":"Risk factors for bleb-related infection following trabeculectomy surgery: Ocular surface findings \u2013 A case-control study","volume":"101","author":"Rai","year":"2017","journal-title":"Br J Ophthalmol"},{"key":"R120-20250605","first-page":"34","article-title":"Complications following use of intraoperative mitomycin-C in pterygium surgery","volume":"6","author":"Ahmad","year":"2004","journal-title":"JK Sci"},{"key":"R121-20250605","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/S0161-6420(92)31750-6","article-title":"Who should receive mitomycin-C after pterygium surgery?","volume":"99","author":"Sugar","year":"1992","journal-title":"Ophthalmology"},{"key":"R122-20250605","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1046\/j.0306-5251.2001.01449.x","article-title":"Effect of local hyperthermia of the bladder on mitomycin C pharmacokinetics during intravesical chemotherapy for the treatment of superficial transitional cell carcinoma","volume":"52","author":"Paroni","year":"2001","journal-title":"Br J Clin Pharmacol"},{"key":"R123-20250605","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1097\/ICO.0000000000001506","article-title":"Systemic absorption of mitomycin-C when used in pterygium surgery","volume":"37","author":"Yulish","year":"2018","journal-title":"Cornea"},{"key":"R124-20250605","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jcrs.2012.08.062","article-title":"Systemic absorption of mitomycin-C when used in refractive surgery","volume":"39","author":"Crawford","year":"2013","journal-title":"J Cataract Refract Surg"},{"issue":"4","key":"R125-20250605","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1007\/s12325-019-00905-w","article-title":"A critical overview of the biological effects of mitomycin C Application on the cornea following refractive surgery","volume":"36","author":"Arranz-Marquez","year":"2019","journal-title":"Adv Ther"},{"key":"R126-20250605","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1159\/000336452","article-title":"Corneal melting two weeks after pterygium excision with topical mitomycin C: Successfully treated with lamellar keratoplasty and amnion membrane transplantation","volume":"3","author":"Menghini","year":"2012","journal-title":"Case Rep Ophthalmol"},{"key":"R127-20250605","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s40123-014-0026-7","article-title":"Use of an autologous lamellar scleral graft to repair a scleral melt after mitomycin application","volume":"3","author":"Polat","year":"2014","journal-title":"Ophthalmol Ther"},{"key":"R128-20250605","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s12886-015-0130-z","article-title":"Biodegradable collagen matrix (Ologen\u2122) implant and conjunctival autograft for scleral necrosis after pterygium excision: Two case reports","volume":"15","author":"Cho","year":"2015","journal-title":"BMC Ophthalmol"},{"key":"R129-20250605","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/ICL.0b013e31822f664f","article-title":"Haemophilus influenza endophthalmitis after pterygium surgery","volume":"39","author":"Kolomeyer","year":"2013","journal-title":"Eye Contact Lens"},{"key":"R130-20250605","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.ophtha.2015.01.019","article-title":"Mitomycin-C in corneal surface excimer laser ablation techniques: A report by the American Academy of Ophthalmology","volume":"122","author":"Majmudar","year":"2015","journal-title":"Ophthalmology"},{"key":"R131-20250605","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.ajo.2007.07.020","article-title":"Low-dose mitomycin C as a prophylaxis for corneal haze in myopic surface ablation","volume":"144","author":"Thornton","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"R132-20250605","first-page":"13","article-title":"Comparison of standard and low dose mitomycin C in the prevention of corneal haze following photorefractive keratectomy","volume":"22","author":"Naderi","year":"2010","journal-title":"Iranian J Ophthalmol"},{"key":"R133-20250605","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.ophtha.2009.10.024","article-title":"Reduced application time for prophylactic mitomycin C in photorefractive keratectomy","volume":"117","author":"Virasch","year":"2010","journal-title":"Ophthalmology"},{"key":"R134-20250605","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/01.icu.0000172830.41394.7c","article-title":"How and when to use mitomycin-C in refractive surgery","volume":"16","author":"Lacayo","year":"2005","journal-title":"Curr Opin Ophthalmol"},{"key":"R135-20250605","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0161-6420(94)31269-3","article-title":"The use of low-dose mitomycin C for prevention of recurrent pterygium","volume":"101","author":"Frucht-Pery","year":"1994","journal-title":"Ophthalmology"},{"key":"R136-20250605","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0161-6420(98)95034-5","article-title":"Intraoperative mitomycin C to prevent recurrence of pterygium after excision: A 30-month follow-up study","volume":"105","author":"Lam","year":"1998","journal-title":"Ophthalmology"},{"key":"R137-20250605","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/S0161-6420(99)90445-1","article-title":"Use of mitomycin C with conjunctival autograft in pterygium surgery in Asian-Canadians","volume":"106","author":"Wong","year":"1999","journal-title":"Ophthalmology"},{"key":"R138-20250605","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.ajo.2005.12.028","article-title":"Conjunctival autografting combined with low-dose mitomycin C for prevention of primary pterygium recurrence","volume":"141","author":"Frucht-Pery","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"R139-20250605","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ophtha.2011.08.002","article-title":"Randomized trial of pterygium surgery with mitomycin C application using conjunctival autograft versus conjunctival-limbal autograft","volume":"119","author":"Kheirkhah","year":"2012","journal-title":"Ophthalmology"},{"key":"R140-20250605","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/IJG.0000000000001438","article-title":"Historical considerations and innovations in the perioperative use of mitomycin C for glaucoma filtration surgery and bleb revisions","volume":"29","author":"Grover","year":"2020","journal-title":"J Glaucoma"},{"key":"R141-20250605","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/ICU.0000000000000729","article-title":"History, presence, and future of mitomycin C in glaucoma filtration surgery","volume":"32","author":"Wolters","year":"2021","journal-title":"Curr Opin Ophthalmol"},{"key":"R142-20250605","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1089\/jir.2018.0125","article-title":"Interferon alpha 2a and 2b in ophthalmology: A review","volume":"39","author":"Lewczuk","year":"2019","journal-title":"J Interferon Cytokine Res"},{"key":"R143-20250605","doi-asserted-by":"crossref","first-page":"14221","DOI":"10.1038\/s41598-022-18545-6","article-title":"Topical pharmacotherapy for ocular surface squamous neoplasia: Systematic review and meta-analysis","volume":"12","author":"Kozma","year":"2022","journal-title":"Sci Rep"},{"issue":"2","key":"R144-20250605","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jtos.2017.12.003","article-title":"Changes in in vivo confocal microscopic findings of ocular surface squamous neoplasia during treatment with topical interferon alfa-2b","volume":"16","author":"Zarei-Ghanavati","year":"2018","journal-title":"Ocul Surf"},{"key":"R145-20250605","doi-asserted-by":"crossref","first-page":"702","DOI":"10.4103\/0301-4738.195010","article-title":"Recombinant interferon alpha 2b for ocular surface squamous neoplasia: An efficient and cost-effective treatment modality in Asian Indian patients","volume":"64","author":"Kaliki","year":"2016","journal-title":"Indian J Ophthalmol"},{"key":"R146-20250605","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/ICU.0b013e3283622a13","article-title":"Topical chemotherapy for ocular surface squamous neoplasia","volume":"24","author":"Nanji","year":"2013","journal-title":"Curr Opin Ophthalmol"},{"key":"R147-20250605","first-page":"CD006259","article-title":"Mitomycin C versus 5-fluorouracil for wound healing in glaucoma surgery","volume":"2015","author":"Cabourne","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"R148-20250605","first-page":"15","article-title":"Efficacy of repeated 5-fluorouracil needling for failing and failed filtering surgeries based on simple gonioscopic examination","volume":"7","author":"Rashad","year":"2013","journal-title":"Clin Ophthalmol"},{"key":"R149-20250605","first-page":"CD012309","article-title":"Antimetabolites as an adjunct to dacryocystorhinostomy for nasolacrimal duct obstruction","volume":"4","author":"Phelps","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"R150-20250605","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10792-011-9509-x","article-title":"5-fluorouracil versus mitomycin C as adjuncts to conjunctival autograft in preventing pterygium recurrence","volume":"32","author":"Bekibele","year":"2012","journal-title":"Int Ophthalmol"},{"key":"R151-20250605","doi-asserted-by":"crossref","first-page":"P61","DOI":"10.1016\/j.ophtha.2022.10.032","article-title":"Refractive surgery preferred practice pattern\u00ae","volume":"130","author":"Jacobs","year":"2023","journal-title":"Ophthalmology"},{"key":"R152-20250605","doi-asserted-by":"crossref","first-page":"898","DOI":"10.3390\/ph16060898","article-title":"Pharmacological approaches to modulate the scarring process after glaucoma surgery","volume":"16","author":"Collotta","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"key":"R153-20250605","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/BF00130852","article-title":"Trabeculectomy with mitomycin C: An electron microscopic and clinical study","volume":"19","author":"Tur\u00e1\u00e7li","year":"1995","journal-title":"Int Ophthalmol"},{"key":"R154-20250605","doi-asserted-by":"crossref","first-page":"225","DOI":"10.12669\/pjms.321.8576","article-title":"The results of photorefractive keratectomy with Mitomycin-C in myopia correction after 5 years","volume":"32","author":"Hashemi","year":"2016","journal-title":"Pak J Med Sci"},{"key":"R155-20250605","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/IJG.0000000000000653","article-title":"Intermediate and long-term outcomes of mitomycin C-enhanced trabeculectomy as a first glaucoma procedure in uveitic glaucoma","volume":"26","author":"Almobarak","year":"2017","journal-title":"J Glaucoma"},{"key":"R156-20250605","doi-asserted-by":"crossref","first-page":"919688","DOI":"10.3389\/fphar.2022.919688","article-title":"Recommendations for off-label drug use in ophthalmology in China: A clinical practice guideline","volume":"13","author":"Li","year":"2022","journal-title":"Front Pharmacol"},{"key":"R157-20250605","doi-asserted-by":"crossref","first-page":"411","DOI":"10.4103\/0301-4738.36472","article-title":"Off-label use of medicines: Medical research and medical practice","volume":"55","author":"Khamar","year":"2007","journal-title":"Indian J Ophthalmol"},{"key":"R158-20250605","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1111\/aos.14195","article-title":"Effectiveness of trabeculectomy with mitomycin C for glaucomatous eyes with low intraocular pressure on treatment eye drops","volume":"98","author":"Yuasa","year":"2020","journal-title":"Acta Ophthalmol"},{"key":"R159-20250605","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jcrs.2005.05.027","article-title":"Photorefractive keratectomy with intraoperative mitomycin-C application","volume":"31","author":"Lee","year":"2005","journal-title":"J Cataract Refract Surg"}],"container-title":["Journal of Current Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/joco.joco_283_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:21:54Z","timestamp":1787836914000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/joco.joco_283_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":159,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/joco.joco_283_23","relation":{},"ISSN":["2452-2325"],"issn-type":[{"value":"2452-2325","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"2023-12-16","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-02","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}